Trial-sourced incidence data
Mounjaro (tirzepatide) has 4 documented side effects from peer-reviewed Phase 3 trial data. Click any effect for a patient-facing deep dive with management guidance.
Nausea
moderate29.6% of trial patientsgastrointestinal
Diarrhea
moderate23% of trial patientsgastrointestinal
Vomiting
moderate12.6% of trial patientsgastrointestinal
Constipation
mild11.7% of trial patientsgastrointestinal
Incidence rates from peer-reviewed pivotal-trial publications and FDA prescribing information. Individual experience varies — discuss any new symptoms with your prescriber. Medically reviewed by Jane Novak, MD, MPH.